IL6 and breast cancer: Using the ORAI1 E106Q pore dead mutant and L273D STIM1 binding-deficient mutant, our study demonstrated that ORAI1 regulation of PTGS2 and IL6 expression in basal breast cancer is dependent on both ORAI1 pore activity and STIM1 binding.